Schedule 13G ownership disclosure

Freeline Therapeutics Holdings plc

Security class unavailable · CUSIP: 35655L107

Event date: 2021-07-30

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,813,984
Percent of class
5.0600%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902219-21-000378
Form type
SC 13G/A
Filer
Freeline Therapeutics Holdings plc
CIK
CIK 1810031
Filed
Aug 10, 2021
Reporting period
Jul 30, 2021
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub